Related Experiment Video
Updated: Aug 13, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection
Busara Songtanin1, Kenneth Nugent1
1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Insights
Hepatitis C virus (HCV) causes liver disease and serious non-liver complications. New treatments offer a cure, but understanding and managing these extrahepatic manifestations remains crucial.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) infection leads to chronic liver disease, cirrhosis, and hepatocellular carcinoma.
- HCV is linked to significant extrahepatic manifestations (EHMs) like cryoglobulinemia, diabetes, and lymphoma.
- These EHMs increase disease complexity, mortality, and healthcare costs globally.
Purpose of the Study:
- To provide an updated review of HCV-associated extrahepatic manifestations.
- To highlight the prevalence, risk factors, and disease burden of HCV EHMs.
- To discuss current treatment strategies for managing HCV EHMs.
Main Methods:
- Literature review of studies on Hepatitis C virus and its extrahepatic manifestations.
- Analysis of prevalence, risk factors, and clinical impact of HCV-associated EHMs.
- Synthesis of information on treatment outcomes and management of these conditions.
Main Results:
- Direct-acting antiviral agents (DAAs) achieve high cure rates and reduce EHM burden.
- Despite effective treatment, HCV EHMs remain a significant clinical concern.
- Understanding viral mechanisms driving EHMs is essential for comprehensive patient care.
Conclusions:
- HCV treatment with DAAs has improved outcomes by reducing EHM incidence and severity.
- Continued research is needed to fully elucidate the pathogenesis of HCV EHMs.
- Managing EHMs is vital for improving the quality of life and survival of HCV patients.
Abstract:
Hepatitis C virus (HCV) is a significant cause of chronic liver diseases worldwide and is associated with negative consequences, including cirrhosis, hepatic decompensation, hepatocellular carcinoma, and increased risk of mortality. In addition to liver-related morbidities, HCV is also associated with several extrahepatic manifestations, including mixed cryoglobulinemia, diabetes mellitus, cardiocerebrovascular disease, lymphoma, and autoimmune diseases. These non-liver-related complications of HCV increase the complexity of this disease and can contribute to the economic burden, morbidity, quality of life, and mortality throughout the world. Therefore, understanding how this virus can contribute to each extrahepatic manifestation is worth investigating. Currently, the advancement of HCV treatment with the advent of direct-acting anti-viral agents (DAAs) has led to a high cure rate as a result of sustained virologic response and tremendously reduced the burden of extrahepatic complications. However, HCV-associated extrahepatic manifestations remain a relevant concern, and this review aims to give an updated highlight of the prevalence, risk factors, associated burdens, and treatment options for these conditions.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Hepatic Drug Excretion: Influencing Factors
Chronic Kidney Disease II: Clinical Manifestations

